Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.

被引：0
|
作者：
Schmitt, J. M.
Sommers, S. R.
Fisher, W. B.
Ansari, R. H.
Robin, E. L.
Koneru, K.
McClean, J. W.
Liu, Z.
Hanna, N. H.
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Med Consultants, Muncie, IN USA
[4] Michiana Hematol Oncol PC, South Bend, IN USA
[5] Community Hosp, Munster, IN USA
[6] Canc Ctr Southern Indiana, Bloomington, IN USA
[7] Med & Surg Specialists LLC, Galesburg, IL USA
[8] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA
[9] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14661
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
    Gogas, H
    Polyzos, A
    Tsoutsos, D
    Panagiotou, P
    Iconomou, T
    Papadopoulos, S
    Papadopoulos, O
    Agarwala, S
    Stavrinidis, I
    Fountzilas, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 723S - 723S
  • [22] A phase II study of lonafarnib (LF) in patients with locally advanced and metastatic breast cancer (MBC): Hoosier Oncology Group BRE07-126
    Leyland-Jones, B.
    Miller, K.
    Silverman, P.
    Shen, C.
    Williams, C. E.
    Breen, T.
    Sledge, G. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] A phase II study of combined VEGF inhibitor (bevacizumab plus sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109
    Mina, Lida A.
    Yu, Menggang
    Johnson, Cynthia
    Burkhardt, Cyndi
    Miller, Kathy D.
    Zon, Robin
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1307 - 1310
  • [24] Phase II trial of gemcitabine plus irinotecan in patients with Esophageal cancer - A Southwest Oncology Group (SWOG) trial
    Williamson, SK
    McCoy, SA
    Gandara, DR
    Dakhil, SR
    Yost, KJ
    Paradelo, JC
    Atkins, JN
    Blanke, CD
    Abbruzzese, JL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 116 - 122
  • [25] Phase II randomized study of paclitaxel and paclitaxel plus PSC 833 for advanced breast cancer
    Spicer, DV
    Groshen, S
    Doroshow, JH
    Synold, T
    Gandara, D
    Russell, C
    Muggia, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S317 - S317
  • [26] Paclitaxel plus ifosfamide in advanced ovarian cancer - A multicenter phase II study
    Miglietta, L
    Amoroso, D
    Bruzzone, M
    Granetto, C
    Catsafados, E
    Mammoliti, S
    Guarneri, D
    Pedulla, F
    Foglia, G
    Ragni, N
    Martini, MC
    Brema, F
    Addamo, G
    Moraglio, L
    Pastorino, G
    Boccardo, F
    ONCOLOGY, 1997, 54 (02) : 102 - 107
  • [27] A Phase II Study of Paclitaxel and Nedaplatin as First-line Chemotherapy in Patients with Advanced Esophageal Cancer
    Cao, Weiguo
    Xu, Chun
    Lou, Guying
    Jiang, Jinsong
    Zhao, Shunguang
    Geng, Mei
    Xi, Wenqi
    Li, Hao
    Jin, Yening
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (09) : 582 - 587
  • [28] A phase I study of amrubicin (AMR) and cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group
    Jalal, S. I.
    Bufill, J. A.
    Masters, G. A.
    Somaiah, N.
    Koneru, K.
    McClean, J.
    Sanborn, R. E.
    Wu, J.
    Yu, Z.
    Einhorn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study.
    Takekuma, M.
    Hirashima, Y.
    Ito, K.
    Tsubamoto, H.
    Tabata, T.
    Arakawa, A.
    Itani, Y.
    Furukawa, N.
    Murakoshi, H.
    Takeuchi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study
    Rothenberg, ML
    Benedetti, JK
    Macdonald, JS
    Seay, TE
    Neubauer, MA
    George, CS
    Tanaka, MS
    Giguere, JK
    Pruitt, BT
    Abbruzzese, JL
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1576 - 1582
12345